Risk Factors for Poor Compliance with Adjuvant S-1 Chemotherapy for Gastric Cancer: A Multicenter Retrospective Study-Reference-Cited by-同舟云学术

Risk Factors for Poor Compliance with Adjuvant S-1 Chemotherapy for Gastric Cancer: A Multicenter Retrospective Study

Published:2017-06-12 Issue:9 Volume:24 Page:2639-2645
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Yamashita Kotaro,Kurokawa Yukinori,Yamamoto Kazuyoshi,Hirota Masashi,Kawabata Ryohei,Mikami Jota,Masuzawa Toru,Takiguchi Shuji,Mori Masaki,Doki Yuichiro

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/article/10.1245/s10434-017-5923-2/fulltext.html

Reference18 articles.

1. Sakuramoto S, Sasako M, Yamaguchi T, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357(18):1810–20.

2. Davis JL, Selby LV, Chou JF, et al. Patterns and predictors of weight loss after gastrectomy for cancer. Ann Surg Oncol. 2016;23(5):1639–45.

3. Takiguchi S, Miyazaki Y, Takahashi T, et al. Impact of synthetic ghrelin administration for patients with severe body weight reduction more than 1 year after gastrectomy: a phase II clinical trial. Surg Today. 2016;46(3):379–85.

4. Kim JW, Jung SY, Cho JW, Kim BC, Chung KS, Yang DH. Postoperative body mass index changes in gastric cancer patients according to reconstruction type: effectiveness of long jejunal bypass on weight loss in obese patients after distal gastrectomy. Indian J Surg. 2014;76(3):187–92.

5. Aoyama T, Yoshikawa T, Shirai J, et al. Body weight loss after surgery is an independent risk factor for continuation of S-1 adjuvant chemotherapy for gastric cancer. Ann Surg Oncol. 2013;20(6):2000–6.

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk Factors for Suboptimal Colon Cancer Diagnosis and Management at a Safety-Net Hospital System;Journal of Surgical Research;2024-09

2. The impact of preoperative skeletal muscle loss on the completion of S-1 adjuvant chemotherapy for gastric cancer;Surgery Today;2024-07-30

3. A retrospective study: exploring the optimal patient population for adjuvant chemotherapy after D2 gastrectomy;Journal of Gastrointestinal Surgery;2024-04

4. Nomogram to predict overall survival of patients receiving radical gastrectomy and incomplete peri-operative adjuvant chemotherapy for stage II/III gastric cancer: a retrospective bi-center cohort study;BMC Cancer;2024-03-18

5. Clinical impact of skeletal muscle mass change during the neoadjuvant chemotherapy period in patients with gastric cancer: An ancillary study of JCOG1002;World Journal of Surgery;2023-12-18